Ciencias de la Salud
Campo de conocimiento
GlaxoSmithKline (Spain)
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de GlaxoSmithKline (Spain) (19)
2019
-
Budget impact analysis of subcutaneous belimumab in patients with systemic lupus erythematosus in Spain
ClinicoEconomics and Outcomes Research, Vol. 11, pp. 757-765
2016
-
Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic copd spanish patients
International Journal of COPD, Vol. 11, pp. 123-132
2015
-
Validation of a Spanish version of the childhood asthma control test (Sc-ACT) for use in Spain
Anales de Pediatria, Vol. 83, Núm. 2, pp. 94-103
2011
-
Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 3, pp. 167-173
2010
-
Geographical variations in the prevalence of COPD in Spain: Relationship to smoking, death rates and other determining factors
Archivos de Bronconeumologia, Vol. 46, Núm. 10, pp. 522-530
-
Recent trends in COPD prevalence in Spain: A repeated cross-sectional survey 1997-2007
European Respiratory Journal, Vol. 36, Núm. 4, pp. 758-765
2009
-
Impact of acute otitis media pathogen shifts on the clinical efficacy of several antibiotics: A therapeutic outcomes model
Journal of Chemotherapy, Vol. 21, Núm. 4, pp. 408-413
2008
-
A retrospective study of the effectiveness of lamotrigine in monotherapy for the treatment of epileptic seizures. The ERELMO study
Revista de Neurologia, Vol. 46, Núm. 4, pp. 197-202
-
Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder
Bipolar Disorders, Vol. 10, Núm. 3, pp. 400-412
2007
-
Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)
Journal of Affective Disorders, Vol. 102, Núm. 1-3, pp. 93-99
-
The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting
International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 2, pp. 146-150
2005
-
Evaluation of antimicrobial treatments in children with acute otitis media in Spain: A pharmacokinetic-pharmacodynamic (PK/PD) approach
Journal of Chemotherapy, Vol. 17, Núm. 6, pp. 628-635
-
In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point
International Journal of Antimicrobial Agents, Vol. 25, Núm. 2, pp. 163-167
2003
-
Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib)
Vaccine, Vol. 21, Núm. 25-26, pp. 3593-3600
-
Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study
Vaccine, Vol. 21, Núm. 23, pp. 3236-3239
-
Evaluación psicométrica comparativa de las versiones en español de 6, 17 y 21 ítems de la Escala de valoración de Hamilton para la evaluación de la depresión
Medicina Clinica, Vol. 120, Núm. 18, pp. 693-700
-
Validación de las versiones en español de la Clinical Anxiety Scale y del Physician Questionnaire para la evaluación de los trastornos de ansiedad
Medicina Clinica, Vol. 121, Núm. 10, pp. 367-374
2002
-
Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain
Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy